Clinical Supply Regulation Resources
-
Sponsor Overcomes Hold And Steers Products Through Development
11/2/2023
Uncover how a small-sized biotech company was able to resolve critical regulatory CMC deficiencies to meet FDA requirements.
-
Overcoming Obstacles To Deliver Critical Autologous Cell Therapy
3/25/2023
See how teams ensured a seamless route, including on-time customs clearance and delivery of autologous cell therapy, from the U.S. to a manufacturing site in Germany
-
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution
9/20/2021
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
Artificial Intelligence Regulation
12/13/2024
To make the best use of artificial intelligence (AI), drug sponsors need to understand where health authorities are drawing the lines.
-
How CDMOs Deliver Precision and Scale in Pharma Spray Drying
1/26/2026
Spray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
-
Highly Potent, Perfectly Packaged
1/12/2023
Experts explore a project to add a contained manufacturing facility and potent packaging suite by discussing the attention to technical detail required to exceed the required high standards and regulatory controls.
-
Global Reach, Biotech Speed: Clinical Packaging, Labeling That Delivers
2/3/2026
By integrating scalable operations, reliable supply chains, and deep regulatory expertise, biotech companies can eliminate bottlenecks, improve efficiency, and accelerate trial execution.
-
How Life Sciences Leaders Are Preparing For More Curveballs In 2026
3/18/2026
Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
-
Investigational Medicinal Products: Labeling Changes And Their Implications
12/16/2022
Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
Transforming The Pharma Supply Chain
7/17/2023
Start leveraging logistics partners with global end-to-end solutions that can help avoid costly delays, ensure high product quality, and accelerate impactful solutions for patients worldwide.